Arsenal Capital Management

InterShunt, founded in 2015 and based in St Louis, Missouri, specializes in designing and developing a catheter-based minimally-invasive procedure aimed at alleviating symptoms for individuals suffering from heart failure. The company focuses on left atrial decompression as a key solution to reduce these symptoms. Their proprietary system involves an interatrial shunting device that does not require an implant or energy source, allowing doctors to lower left atrial pressure in patients with heart failure through a simple catheter procedure.

Juristat transforms public patent data into actionable analytics for law firms and in-house counsel. Its platform analyzes USPTO examiner behavior to optimize patent prosecution strategies, increasing allowance rates, decreasing time to allowance, and reducing costs.

Kypha Inc. is a life sciences company focused on the discovery, development, and commercialization of in-vitro diagnostic biomarker tests targeting inflammation and autoimmune disorders. Based in St. Louis, Missouri, the company offers the COMP ACT System, which enhances the monitoring and treatment of various health conditions, including lupus, stroke, traumatic brain injury, preeclampsia, infection, kidney disease, and transplant rejection. Through its innovative platform, Kypha provides rapid and accurate assessments of inflammation levels, enabling healthcare professionals to make timely and informed clinical decisions. The company's approach facilitates testing across diverse settings, from home health care to clinical laboratories, ultimately aiming to improve patient outcomes by optimizing treatment strategies based on real-time immune insights. Since its incorporation in 2009, Kypha has attracted significant funding and built a strong network of scientific and clinical expertise to support its mission.

Deck Commerce is a developer of a cloud-based order management platform aimed at enhancing e-commerce operations for retailers. The platform addresses common challenges in data management, system integration, and business processes faced by e-commerce businesses. It provides features such as enterprise inventory visibility, universal product information, and distributed order management. By connecting front-end shopping channels with back-end business systems, Deck Commerce enables small to mid-sized e-commerce businesses to efficiently manage their orders, inventory, and product data while leveraging their existing systems. This streamlined approach allows retailers to operate more effectively in a competitive retail environment.

Kypha Inc. is a life sciences company focused on the discovery, development, and commercialization of in-vitro diagnostic biomarker tests targeting inflammation and autoimmune disorders. Based in St. Louis, Missouri, the company offers the COMP ACT System, which enhances the monitoring and treatment of various health conditions, including lupus, stroke, traumatic brain injury, preeclampsia, infection, kidney disease, and transplant rejection. Through its innovative platform, Kypha provides rapid and accurate assessments of inflammation levels, enabling healthcare professionals to make timely and informed clinical decisions. The company's approach facilitates testing across diverse settings, from home health care to clinical laboratories, ultimately aiming to improve patient outcomes by optimizing treatment strategies based on real-time immune insights. Since its incorporation in 2009, Kypha has attracted significant funding and built a strong network of scientific and clinical expertise to support its mission.

Aptimmune is a biotechnology company headquartered in St. Louis, Missouri, established in 2010. It specializes in the development of mucosal vaccines aimed at preventing viral diseases in swine, specifically targeting the Porcine Reproductive and Respiratory Syndrome virus (PRRSV) and influenza A virus. By employing innovative technologies, including a proprietary pig alveolar macrophage cell line known as ZMAC, Aptimmune creates effective nasal delivery vaccines that provide lasting immune responses and enhance disease protection for animal breeders.

Deck Commerce is a developer of a cloud-based order management platform aimed at enhancing e-commerce operations for retailers. The platform addresses common challenges in data management, system integration, and business processes faced by e-commerce businesses. It provides features such as enterprise inventory visibility, universal product information, and distributed order management. By connecting front-end shopping channels with back-end business systems, Deck Commerce enables small to mid-sized e-commerce businesses to efficiently manage their orders, inventory, and product data while leveraging their existing systems. This streamlined approach allows retailers to operate more effectively in a competitive retail environment.

PowerPublish provides a virtual newsroom and content publishing platform that uses technology and automation to help brands become power publishers. It enables the curation, creation, and publication of premium content at scale across social channels, enhances brand voice and search authority, and monitors marketing performance. The platform supports monetization of content and expertise for companies and brands.

Founded in 2013, Bonfyre operates an employee engagement platform that facilitates communication, recognition, feedback, events, and more. Its mobile-first, real-time tools help enterprises build camaraderie, align culture, and drive HR business intelligence.

Founded in 2013, Bonfyre operates an employee engagement platform that facilitates communication, recognition, feedback, events, and more. Its mobile-first, real-time tools help enterprises build camaraderie, align culture, and drive HR business intelligence.

Harbor MedTech is a regenerative medicine company focused on developing and commercializing tissue regeneration products for wound care, hernia and joint repair, and related surgical applications. Its product portfolio includes Architect, an extracellular collagen matrix used to treat partial- and full-thickness skin wounds such as diabetic ulcers and venous ulcers; and EPMatrix, a collagen scaffold for soft tissue repair and reinforcement. The company leverages its BriDGE platform to create solutions across breast reconstruction, hernia repair, and orthopedic and dermatologic applications. It also markets NeuvoCell, a wound therapy for chronic wounds. Harbor MedTech, founded in 2010, is headquartered in Irvine, California.

Synek created the SYNEK beer dispenser and personally thanked every backer by taking a 42-city RV tour to deliver the 2,500 pre-ordered dispensers. The SYNEK beer dispenser refrigerates, pressurizes, and dispenses beer in the coolest way possible—brewery-quality beer, fresh on draft, in your home.

Wellopp develops a social health intelligence platform for chronic care management that uses data from social determinants of health to engage patients and deliver a personalized care experience across medical and social needs. The platform provides behavioral change tools and integrates patient data to help physicians improve quality, manage costs, and reduce readmission rates. By addressing non-medical factors that influence outcomes, Wellopp supports healthcare systems in delivering coordinated, patient-centered care while maintaining privacy and compliance with HIPAA.

KEW, Inc., established in 2009 and headquartered in Cambridge, Massachusetts, specializes in genomic testing services for cancer patients. The company's core offering, CANCERPLEX, is a precision medicine service that analyzes a patient's genetic drivers to help oncologists select personalized, targeted therapies. KEW's suite of products includes CANCERPLEX FP, a full panel test with immunotherapy options, CANCERPLEX TS for common tumor sites, and CANCERPLEX TX for FDA-approved targeted therapies. The company delivers these solutions through strategic partnerships and distributors, enabling evidence-driven treatment decisions in cancer care.

Kypha Inc. is a life sciences company focused on the discovery, development, and commercialization of in-vitro diagnostic biomarker tests targeting inflammation and autoimmune disorders. Based in St. Louis, Missouri, the company offers the COMP ACT System, which enhances the monitoring and treatment of various health conditions, including lupus, stroke, traumatic brain injury, preeclampsia, infection, kidney disease, and transplant rejection. Through its innovative platform, Kypha provides rapid and accurate assessments of inflammation levels, enabling healthcare professionals to make timely and informed clinical decisions. The company's approach facilitates testing across diverse settings, from home health care to clinical laboratories, ultimately aiming to improve patient outcomes by optimizing treatment strategies based on real-time immune insights. Since its incorporation in 2009, Kypha has attracted significant funding and built a strong network of scientific and clinical expertise to support its mission.

TransMed Systems, Inc. is a software development company that specializes in creating tools for the analysis and application of transactional data within the healthcare sector. Based in Cupertino, California, with additional offices in Washington, D.C., Chicago, Illinois, and Columbus, Ohio, the company offers a range of products, including the TransMed Suite, which provides an integrated platform for translational medicine. This suite supports the complete workflow from data aggregation to clinical application. Key offerings include the Adaptive Healthcare Unified Bioclinical system, which facilitates healthcare data management, the Clinically Actionable Report Engine that translates research discoveries into clinical practice, and the Bio-Informatics Suite that streamlines the translational research process. TransMed Systems' solutions are designed to empower health sciences researchers and clinicians by providing self-service access to aggregated bio-clinical data, enhancing their ability to conduct research and improve clinical practices. The company also maintains a strategic alliance with Pharmatech Inc.